InMode Anticipates Strong Q2 2026 Results with Revenue Forecast of Up to $95.4M

InMode to Release Q2 2026 Financial Results

InMode Ltd., a renowned leader in innovative medical technologies, headquartered in Yokneam, Israel, has announced it will disclose its financial results for the second quarter of 2026. The anticipated announcement is scheduled for August 5, 2026, prior to the opening of the Nasdaq market.

The company, listed on NASDAQ under the symbol INMD, is at present finalizing its Q2 financial data. Although full results and operational details are not yet finalized, preliminary earnings estimates indicate a revenue range between $95.2 million and $95.4 million for the quarter. Furthermore, InMode has reaffirmed its full-year revenue guidance for 2026, expecting totals between $365 million and $375 million, reflecting a confident outlook on its market performance.

The release will be particularly significant as InMode navigates various strategic proposals under review by its Special Committee. In light of these developments, InMode will not be organizing an investor conference call or webcast following this earnings announcement and will refrain from conducting any investor meetings at this time.

About InMode

InMode specializes in the development, manufacturing, and marketing of devices that utilize cutting-edge radio frequency (RF) technology. Its innovative products aim to facilitate emerging surgical procedures and enhance existing treatments, making a significant impact in fields such as plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. With a commitment to minimally invasive solutions, InMode has built a comprehensive portfolio that aligns with the latest advancements in medical technology.

InMode's dedication to quality and innovation positions it at the forefront of the medical technology industry, enabling healthcare professionals to deliver superior results. For further information about their offerings, interested parties can visit InMode's official website.

Forward-Looking Statements

It's crucial to note that the information mentioned in this press release includes forward-looking statements related to the company's expected financial performance and operational outcomes. Actual results may vary significantly from the forecasts presented due to inherent uncertainties and risks. Investors are encouraged to consider the potential risk factors outlined in InMode's Annual Report on Form 20-F submitted to the Securities and Exchange Commission.

As InMode prepares for this upcoming announcement, stakeholders remain hopeful about the company's strategic direction and its ability to continue delivering on its promises. The financial community will be keenly observing these developments, reflecting the company's status as a pioneering entity in the medical technology landscape.